Cellectis (CLLS) EPS (Weighted Average and Diluted) (2019 - 2021)
Historic EPS (Weighted Average and Diluted) for Cellectis (CLLS) over the last 4 years, with Q2 2021 value amounting to -$34.12.
- Cellectis' EPS (Weighted Average and Diluted) rose 1962.84% to -$34.12 in Q2 2021 from the same period last year, while for Jun 2021 it was -$34.12, marking a year-over-year increase of 1962.84%. This contributed to the annual value of -$2.33 for FY2022, which is 862.75% up from last year.
- Cellectis' EPS (Weighted Average and Diluted) amounted to -$34.12 in Q2 2021, which was up 1962.84% from -$42.45 recorded in Q2 2020.
- Cellectis' EPS (Weighted Average and Diluted)'s 5-year high stood at -$29.08 during Q2 2019, with a 5-year trough of -$42.45 in Q2 2020.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$35.22, with a median of -$34.12 in 2021.
- In the last 5 years, Cellectis' EPS (Weighted Average and Diluted) tumbled by 4595.93% in 2020 and then skyrocketed by 1962.84% in 2021.
- Cellectis' EPS (Weighted Average and Diluted) (Quarter) stood at -$29.08 in 2019, then plummeted by 45.96% to -$42.45 in 2020, then grew by 19.63% to -$34.12 in 2021.
- Its last three reported values are -$34.12 in Q2 2021, -$42.45 for Q2 2020, and -$29.08 during Q2 2019.